(Q44633284)

4 December 2017

title

Topiramate concentration in saliva: an alternative to serum monitoring (English)

1 reference

4 December 2017

1 reference

1 reference

https://api.crossref.org/works/10.1016/S0887-8994(03)00048-1

25 March 2024

4

Melody A. Ryan

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14580658

25 March 2024

Michael V. Miles

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14580658

25 March 2024

Peter H. Tang

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14580658

25 March 2024

Tracy A. Glauser

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14580658

25 March 2024

Shellee A. Grim

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14580658

25 March 2024

Richard H. Strawsburg

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14580658

25 March 2024

Ton J. deGrauw

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14580658

25 March 2024

Robert J. Baumann

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14580658

25 March 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14580658

25 March 2024

publication date

1 August 2003

1 reference

full work available at URL

4 December 2017

https://api.elsevier.com/content/article/PII:S0887899403000481?httpAccept=text/xml

1 reference

DOI

https://api.crossref.org/works/10.1016/S0887-8994(03)00048-1

https://api.elsevier.com/content/article/PII:S0887899403000481?httpAccept=text/plain

25 March 2024

1 reference

DOI

https://api.crossref.org/works/10.1016/S0887-8994(03)00048-1

25 March 2024

1 reference

4 December 2017

volume

29

1 reference

4 December 2017

issue

2

1 reference

4 December 2017

page(s)

143-147

1 reference

Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 600-, 800-, and 1,000-mg daily dosages. Topiramate YE Study Group

4 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2803%2900048-1

7 January 2021

Double-blind, placebo-controlled trial of topiramate (600 mg daily) for the treatment of refractory partial epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2803%2900048-1

7 January 2021

A randomized, placebo-controlled study of topiramate in primary generalized tonic-clonic seizures. Topiramate YTC Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2803%2900048-1

7 January 2021

A double-blind, randomized trial of topiramate as adjunctive therapy for partial-onset seizures in children. Topiramate YP Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2803%2900048-1

7 January 2021

Childhood head tremor

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2803%2900048-1

7 January 2021

Newer antiepileptic drugs: advantages and disadvantages

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2803%2900048-1

7 January 2021

Topiramate versus bupropion SR when added to mood stabilizer therapy for the depressive phase of bipolar disorder: a preliminary single-blind study

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2803%2900048-1

7 January 2021

Use of topiramate in treatment-resistant bipolar spectrum disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2803%2900048-1

7 January 2021

A double-blind placebo-controlled trial of topiramate treatment for essential tremor

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2803%2900048-1

7 January 2021

Antiepileptic drugs in the management of cluster headache and trigeminal neuralgia

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2803%2900048-1

7 January 2021

Topiramate in migraine prevention: a double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2803%2900048-1

7 January 2021

Topiramate use in obese patients with binge eating disorder: an open study.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2803%2900048-1

7 January 2021

Is there a role for therapeutic drug monitoring of new anticonvulsants?

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2803%2900048-1

7 January 2021

Serum concentrations of topiramate in patients with epilepsy: influence of dose, age, and comedication

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2803%2900048-1

7 January 2021

Topiramate therapeutic monitoring in patients with epilepsy: effect of concomitant antiepileptic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2803%2900048-1

7 January 2021

Clinical experience with topiramate dosing and serum levels in children 12 years or under with epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2803%2900048-1

7 January 2021

Therapeutic monitoring of the new antiepileptic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2803%2900048-1

7 January 2021

Topiramate rapidly raises brain GABA in epilepsy patients

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2803%2900048-1

7 January 2021

Modulation of cerebral GABA by topiramate, lamotrigine, and gabapentin in healthy adults

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2803%2900048-1

7 January 2021

Plasma concentration of topiramate correlates with cerebrospinal fluid concentration

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2803%2900048-1

7 January 2021

Topiramate and phenytoin pharmacokinetics during repetitive monotherapy and combination therapy to epileptic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2803%2900048-1

7 January 2021

Topiramate kinetics during delivery, lactation, and in the neonate: preliminary observations

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2803%2900048-1

7 January 2021

Pediatric patients with undetectable anticonvulsant blood levels: comparison with compliant patients

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2803%2900048-1

7 January 2021

Therapeutic drug monitoring in saliva. An update

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2803%2900048-1

7 January 2021

Saliva versus blood sampling for therapeutic drug monitoring in children: patient and parental preferences and an economic analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2803%2900048-1

7 January 2021

Therapeutic drug concentration monitoring using saliva samples. Focus on anticonvulsants

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2803%2900048-1

7 January 2021

An improved gas chromatography assay for topiramate monitoring in pediatric patients

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2803%2900048-1

7 January 2021

Long-term response to topiramate in patients with West syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2803%2900048-1

7 January 2021

A study of topiramate pharmacokinetics and tolerability in children with epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2803%2900048-1

7 January 2021

Topiramate pharmacokinetics in infants

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2803%2900048-1

7 January 2021

Interaction of topiramate with carbamazepine: two case reports and a review of clinical experience

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2803%2900048-1

7 January 2021

Identifiers

DOI

1 reference

4 December 2017

1 reference